Gilead Sciences Inc. (NASDAQ: GILD) has been on fire, so much that two insiders decided to stuff their holiday stockings with about $23 million in stock sales.
Chairman and CEO John Martin sold 282,242 shares from options for $20.96 million on December 2. The price of $74.26 versus a 52-week trading range of $35.68 to $76.11. Gilead is the first biotech to pass the $100 billion market value mark and this sale was effectively close to all-time highs. We would point out that it was part of a 10b5-1 scheduled insider sale plan. The second sale was from VP Gregg Alton for 30,000 for $2.22 million. These were also via options and an existing 105b-1 plan.
Gilead was also featured as our own top growth engine among large cap biotechs when it comes to expected 2014 revenue growth. Its hepatitis C treatment may even bring more growth than we had originally projected in 2014 and in 2015.
Gilead shares were down 3% at $72.90 in late-Tuesday trading and profit taking along with insider selling seems to be why. We would point out that Gilead’s consensus price target from the Thomson Reuters consensus is now up at $84.58.
Stay tuned going into year-end. We will be featuring more instances of insider selling where millions of dollars are raised by insiders cashing in their chips at or close to all-time highs.
Take Charge of Your Retirement In Just A Few Minutes (Sponsor)
Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.
Here’s how it works:
- Answer a Few Simple Questions. Tell us a bit about your goals and preferences—it only takes a few minutes!
- Get Matched with Vetted Advisors Our smart tool matches you with up to three pre-screened, vetted advisors who serve your area and are held to a fiduciary standard to act in your best interests. Click here to begin
- Choose Your Fit Review their profiles, schedule an introductory call (or meet in person), and select the advisor who feel is right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.